288 related articles for article (PubMed ID: 16919027)
21. Signal transducer and activator of transcription-3 expression and activation is dysregulated in actinic cheilitis.
Cury PR; Furuse C; de Araújo NS; de Araújo VC
J Cutan Pathol; 2007 Aug; 34(8):606-11. PubMed ID: 17640230
[TBL] [Abstract][Full Text] [Related]
22. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
[TBL] [Abstract][Full Text] [Related]
23. Loss of cytokeratin 10 indicates malignant transformation in actinic cheilitis.
Garcia NG; Oliveira DT; Lauris JR; Domingues MA; Minicucci EM; Soares CT
Clin Oral Investig; 2016 May; 20(4):745-52. PubMed ID: 26264639
[TBL] [Abstract][Full Text] [Related]
24. Malignant transformation of actinic cheilitis: A systematic review of observational studies.
Dancyger A; Heard V; Huang B; Suley C; Tang D; Ariyawardana A
J Investig Clin Dent; 2018 Nov; 9(4):e12343. PubMed ID: 29863311
[TBL] [Abstract][Full Text] [Related]
25. Actinic cheilitis: histologic study of the entire vermilion and comparison with previous biopsy.
Menta Simonsen Nico M; Rivitti EA; Lourenço SV
J Cutan Pathol; 2007 Apr; 34(4):309-14. PubMed ID: 17381801
[TBL] [Abstract][Full Text] [Related]
26. Density and migration of mast cells in lip squamous cell carcinoma and actinic cheilitis.
Costa NL; Oton-Leite AF; Cheim-Júnior AP; Alencar Rde C; Bittar GO; Silva TA; Batista AC
Histol Histopathol; 2009 Apr; 24(4):457-65. PubMed ID: 19224448
[TBL] [Abstract][Full Text] [Related]
27. Paying more than lip service to lip lesions.
Bentley JM; Barankin B; Lauzon GJ
Can Fam Physician; 2003 Sep; 49():1111-6. PubMed ID: 14526863
[TBL] [Abstract][Full Text] [Related]
28. Increased mast cell density and protease content in actinic cheilitis.
Rojas IG; Martínez A; Pineda A; Spencer ML; Jiménez M; Rudolph MI
J Oral Pathol Med; 2004 Oct; 33(9):567-73. PubMed ID: 15357678
[TBL] [Abstract][Full Text] [Related]
29. Actinic cheilitis: clinical and pathologic characteristics in 65 cases.
Markopoulos A; Albanidou-Farmaki E; Kayavis I
Oral Dis; 2004 Jul; 10(4):212-6. PubMed ID: 15196142
[TBL] [Abstract][Full Text] [Related]
30. Study of MDM2 and SUMO-1 expression in actinic cheilitis and lip cancer.
Oliveira Alves MG; da Mota Delgado A; Balducci I; Carvalho YR; Cavalcante AS; Almeida JD
Arch Dermatol Res; 2014 Nov; 306(9):837-41. PubMed ID: 25241153
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of DNA methyltransferases 1, 3a, and 3b in actinic cheilitis and lip squamous cell carcinomas.
Daniel FI; Alves SR; Vieira DS; Biz MT; Daniel IW; Modolo F
J Oral Pathol Med; 2016 Nov; 45(10):774-779. PubMed ID: 27159259
[TBL] [Abstract][Full Text] [Related]
32. Histopathologic features in actinic cheilitis by the comparison of grading dysplasia systems.
Pilati S; Bianco BC; Vieira D; Modolo F
Oral Dis; 2017 Mar; 23(2):219-224. PubMed ID: 27759902
[TBL] [Abstract][Full Text] [Related]
33. WNT-5A, but not matrix metalloproteinase 3 or beta-catenin protein, expression is related to early stages of lip carcinogenesis.
Xavier FC; Rodini CO; Ramalho LM; Mantesso A; Nunes FD
J Oral Pathol Med; 2009 Oct; 38(9):708-15. PubMed ID: 19473452
[TBL] [Abstract][Full Text] [Related]
34. Laminin Immunostaining in Biopsies as a Useful Biomarker of Early Invasion in Actinic Cheilitis and Differential Diagnosis Between Actinic Cheilitis and Lip Cancer: New Insights.
Vageli D; Doukas PG; Zacharouli K; Kakanis V; Strataki M; Zioga A; Skoulakis C; Koukoulis G; Ioannou M
Head Neck Pathol; 2023 Jun; 17(2):331-338. PubMed ID: 36303015
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the efficacy of photodynamic therapy for the treatment of actinic cheilitis.
Chaves YN; Torezan LA; Lourenço SV; Neto CF
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):14-21. PubMed ID: 27864997
[TBL] [Abstract][Full Text] [Related]
36. Actinic cheilitis: epithelial expression of COX-2 and its association with mast cell tryptase and PAR-2.
Rojas IG; Martínez A; Brethauer U; Grez P; Yefi R; Luza S; Marchesani FJ
Oral Oncol; 2009 Mar; 45(3):284-90. PubMed ID: 18674950
[TBL] [Abstract][Full Text] [Related]
37. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion.
Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M
J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432
[TBL] [Abstract][Full Text] [Related]
38. Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.
Correa GT; Bernardes VF; de Sousa SF; Diniz MG; Salles JM; Souza RP; De-Paula AM; Gomez RS; Gomes CC
Tumour Biol; 2015 Nov; 36(11):9059-66. PubMed ID: 26084614
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of mismatch proteins in carcinogenesis of the lower lip.
Sarmento DJ; de Almeida WL; Miguel MC; Queiroz LM; Godoy GP; da Cruz MC; da Silveira EJ
Histopathology; 2013 Sep; 63(3):371-7. PubMed ID: 23865379
[TBL] [Abstract][Full Text] [Related]
40. Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis.
Pham TT; Ongkeko WM; An Y; Yi ES
Laryngoscope; 2007 Feb; 117(2):253-7. PubMed ID: 17277618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
